15 May 2017

Patheon to be acquired by Thermo Fisher Scientific in a USD 7.2 billion recommended tender offer

Thermo Fisher Scientific will commence a tender offer to acquire all of the issued and outstanding shares of Patheon for USD 35.00 per share in cash. The transaction represents a purchase price of approximately USD 7.2 billion, which includes the assumption of approximately USD 2.0 billion of net debt.

Team: Paul Cronheim, Tijmen Klein Bronsvoort and Rick van ‘t Wout.